Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by skyhigh123on Jun 15, 2018 9:50am
197 Views
Post# 28177074

we are in the news ( good or bad only facts )

we are in the news ( good or bad only facts )

Canada stocks higher at close of trade; S&P/TSX Composite up 0.39%

Investing.com-16 hours ago
The worst performers of the session were ProMetic Life Sciences Inc. (TO:PLI), ... Shares in ProMetic Life Sciences Inc. (TO:PLI) fell to 3-years lows; losing 6.15% ...

Bullboard Posts